%0 Journal Article
%T [Profile of prescription and adequacy of treatment with non-steroidal anti-inflammatory drugs in diabetic patients].
%A Navarro-Martínez A
%A Vidal-Martínez M
%A García-Rosa I
%A Lázaro-Gómez MJ
%A Brotons-Román J
%J Rev Calid Asist
%V 30
%N 5
%D Sep-Oct 2015
%M 26346581
暂无%R 10.1016/j.cali.2015.06.007
%X <B>OBJECTIVE: </B>The aim of this study was to quantify and describe the prescription profile, as well as to assess the adequacy of treatment with non-steroidal anti-inflammatory drugs (NSAIDs) in the diabetic population of a health district.<BR><B>METHODS: </B>This is a descriptive, cross-sectional study aimed at a target population of 2,795 diabetic patients. Data were collected from the computerised clinical records of a sample of 380 individuals. The adequacy of treatment was assessed using the recommendations proposed by the Spanish societies of Rheumatology, Cardiology and Gastroenterology.<BR><B>RESULTS: </B>More than one-quarter (28%) of the diabetic patients received treatment with NSAIDs. The most commonly used ones were ibuprofen, naproxen, and dexketoprofen, with a defined daily dose per 1,000 inhabitants per day of 35.3, 17.2, and 13.2, respectively. In patients with a history of chronic kidney disease and cardiovascular high risk, fewer NSAIDs were prescribed, while they were used most frequently in patients with a risk for gastrointestinal adverse events. The prescription was considered adequate in 46.5% of diabetic patients. The main causes of inappropriate use were the inadequate prescription of NSAIDs (25.2%), and the use of any NSAID other than naproxen (20.6%).<BR><B>CONCLUSIONS: </B>The most prescribed NSAIDs were those showing a low cardiovascular risk profile. Treatment with NSAIDs was inadequate in more than half of the patients. Risk factors for cardiovascular, and especially gastrointestinal, events must be considered in order to avoid its use when not indicated, as well as the use of any NSAIDs other than naproxen.